Pharmaceutical companies abuse the patent system, preventing competition and keeping drug prices high through tactics like patent thickets and pay-for-delay deals.
PhRMA suggests that pharmacy benefit managers and insurers are responsible for blocking competition and increasing costs by denying coverage for low-cost generics to maximize profits.
Collection
[
|
...
]